These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26681491)

  • 1. Influence of author's affiliation and funding sources on the results of cohort studies on occupational cancer.
    Rollin L; Griffon N; Darmoni SJ; Gehanno JF
    Am J Ind Med; 2016 Mar; 59(3):221-6. PubMed ID: 26681491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial support for research in radiology: a survey of original investigations published in the AJR and Radiology.
    Mussurakis S
    AJR Am J Roentgenol; 1994 Oct; 163(4):973-9; discussion 981-2. PubMed ID: 8092046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin and funding of the most frequently cited papers in medicine: database analysis.
    Patsopoulos NA; Ioannidis JP; Analatos AA
    BMJ; 2006 May; 332(7549):1061-4. PubMed ID: 16547014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancy between results and abstract conclusions in industry- vs nonindustry-funded studies comparing topical prostaglandins.
    Alasbali T; Smith M; Geffen N; Trope GE; Flanagan JG; Jin Y; Buys YM
    Am J Ophthalmol; 2009 Jan; 147(1):33-38.e2. PubMed ID: 18760766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A descriptive analysis of the Journal of Manipulative and Physiological Therapeutics, 1989-1996.
    Keating JC; Caldwell S; Nguyen H; Saljooghi S; Smith B
    J Manipulative Physiol Ther; 1998 Oct; 21(8):539-52. PubMed ID: 9798183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
    Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
    Liyanage SS; Raina Macintyre C
    Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. News media coverage of medication research: reporting pharmaceutical company funding and use of generic medication names.
    Hochman M; Hochman S; Bor D; McCormick D
    JAMA; 2008 Oct; 300(13):1544-50. PubMed ID: 18827211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflicts of interest in government-funded studies.
    Pickar JH
    Climacteric; 2015 Jun; 18(3):339-42. PubMed ID: 25690623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
    J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.
    Montgomery JH; Byerly M; Carmody T; Li B; Miller DR; Varghese F; Holland R
    Control Clin Trials; 2004 Dec; 25(6):598-612. PubMed ID: 15588746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
    Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
    CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The magnitude and nature of unfunded published cardiovascular research.
    Mai TV; Agan DL; Clopton P; Collins G; DeMaria AN
    J Am Coll Cardiol; 2013 Jan; 61(3):275-81. PubMed ID: 23219303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research.
    Jagsi R; Sheets N; Jankovic A; Motomura AR; Amarnath S; Ubel PA
    Cancer; 2009 Jun; 115(12):2783-91. PubMed ID: 19434666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conflict of interest in industry-funded medical research].
    Di Pietrantonj C; Demicheli V
    Epidemiol Prev; 2005; 29(2):85-95. PubMed ID: 16124740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs.
    Tibau A; Bedard PL; Srikanthan A; Ethier JL; Vera-Badillo FE; Templeton AJ; Ocaña A; Seruga B; Barnadas A; Amir E
    J Clin Oncol; 2015 Jan; 33(1):100-6. PubMed ID: 25385736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is research presented at the scoliosis research society annual meeting influenced by industry funding?
    Roach JW; Skaggs DL; Sponseller PD; Macleod LM
    Spine (Phila Pa 1976); 2008 Sep; 33(20):2208-12. PubMed ID: 18725871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between declared funding support and level of evidence.
    Noordin S; Wright JG; Howard A
    J Bone Joint Surg Am; 2010 Jul; 92(7):1647-51. PubMed ID: 20595572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.